Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • sazz
    Member
    • Oct 2012
    • 28

    GSEA for RNA-seq data

    Hello,

    We have performed an RNA-seq analysis with Tuxedo Tools. There are 2 conditions and 3 replicates for each, and we have detected differentially expressed genes with 0.01 q cut-off.

    Now, it is time to get meaningful results by comparing with certain gene sets. I have used DAVID at the first step, then now, I am trying to use GSEA, but I have some questions in my mind.

    - Should I load all the replicate FPKM values for each condition as input?
    - Should I load all the genes without cut off?

    Note: They say, you can use "Fpkm_trackingToGct" program from Genepattern. In this case you load the fpkm_tracking file of cuffdiff output and it gives you an output in .gct format which is going to be used as input in GSEA. In this case, that output includes the overall calculated value for 3 replicates (not all of them seperately). If this is the case, I assume I should use a cut-off when loading the genes because the program won't be able to calculate the variation btw replicates, but I also don't know if this leads to some bias.
  • yzzhang
    Member
    • Jan 2013
    • 67

    #2
    Hi, sazz, have solve your problem? I also wonder these things. If you get good solution, could you kindly share it? Thanks in advance.

    Comment

    • sazz
      Member
      • Oct 2012
      • 28

      #3
      Hi yzzhang,

      I wrote to gsea developers, that's the answer:

      "The best approach would be to create a GCT file where rows are gene identifiers
      (ideally, unique instances of human gene symbols), columns are the biological
      replicates for each of two phenotypes and the values are FPKM values.

      In any case, you should avoid filtering your data in any way because this would
      significantly reduce power of GSEA."

      But apart from this problem, I don't trust the ranking methods, ttest or signal2noise are not that much suitable for that kind of analysis. Even the formulas of those methods cares about the variation between replicates, it does not fit to the logic of CuffDiff significancy calculations. You can check the ranked list at the end, and you will see that the ones with very low expressions but also with a low variancy, are not in the "significant list" in CuffDiff but in high ranks at GSEA output, probably because of their low expressions; so a formula that considers the q-value of CuffDiff and log2fold change would be best; so you can do a pre-ranking; but I haven't found something like this yet; and also my statistics is not that good and I can't figure it out on my own.

      Actually in the paper of "Differential analysis of gene regulation at transcript resolution with RNA-seq" of Cole Trapnell, they use GSEA after RNA-seq and in the methods part, they say:

      "Enrichment for up- or downregulation sets of genes from the REACTOME pathway database was computed by running GSEA against the fold-change ranked list of genes in the experiment. Ranking was based on Cuffdiff 2–derived fold change."

      So they say, they used fold change at the CuffDiff result but this can't be that simple, just disregarding the q-value. I asked to Cole Trapnell by mail but he didn't respond.

      Comment

      • yzzhang
        Member
        • Jan 2013
        • 67

        #4
        Hi, sazz,
        Thanks a lot. I appreciate your help, and I will think if this method is suitable for my data. Thanks again.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:41 AM
        0 responses
        9 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        45 views
        0 reactions
        Last Post SEQadmin2  
        Working...